About BOP Annual Meeting with MSKCC 2023

YOU ARE INVITED

Please join us for the Band of Parents annual meeting with the Memorial Sloan Kettering Cancer Center Neuroblastoma Team. The meeting will be in-person, with an option to participate via live-streaming.

Prior to the meeting, we will be hosting our Band of Parents Annual Hope and Light Awards, honoring and recognizing families and individuals who have generated awareness for pediatric cancer and supported our fight against neuroblastoma. We will also thank a small group of donors who have given extraordinary gifts this past year.

WHAT: A unique opportunity to hear about the latest research and upcoming trials. There will also be a chance to ask the doctors any general questions you may have.

WHEN: Wednesday, January 25, 2023 - 6:00 PM - 8:30 PM ET

WHERE: Zuckerman Research Center Room ZRC-105 - MSKCC, 417 East 68th Street, New York, NY 10065 and online - a link for the virtual meeting will be provided after you RSVP and register. 

PLEASE RSVP BY JANUARY 6, 2023


Attendance is limited to BOP Members. If you would like to become a member, please email priscilla@bandofparents.org

Date

Starts at:  January 25, 2023 5:00 PM
Ends at:  January 25, 2023 7:30 PM

Location

Zuckerman Research Center ZRC-105
417 East 68th Street
New York,NY 10065 USA

Contact

Priscilla Ma
priscilla@bandofparents.org

How Your Support Makes a Difference

With your support, we can find a cure for neuroblastoma, while reducing the highly toxic nature of treatment. One day, we hope antibodies will replace chemotherapy.

Band of Parents is the top independent backer of neuroblastoma research at Memorial Sloan-Kettering Cancer Center (MSKCC). Our mission is to seek projects that have already been examined in the lab and are in need of assistance to rapidly move into a patient population. In the 1980s, fewer than 5% of children diagnosed with high risk neuroblastoma survived. Although today, most major medical centers like MSKCC have over a 50% survival rate, far too many children are still dying of this disease. The sad fact is that due to the high cost of research and the small number of children diagnosed annually, pediatric cancer is severely underfunded by both the pharmaceutical industry and the federal government. Less than 4% of the National Cancer Institute’s funding goes to fight pediatric cancer. We support our members through their children’s battle with neuroblastoma. Together, we are Bound by Hope that a cure is out there. We will continue this fight until not a single child is lost to this disease.